(PharmaNewsWire.Com, July 26, 2017 ) North America Tumor Ablation Market was worth $123.75 million in 2016 and estimated to be growing at a CAGR of 11.2%, to reach $210.41 million by 2021.Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung and liver. Rising Prevalence of cancer is proportional to the growth of tumor ablation market. As per data published by the American Cancer Society, the incidence of cancer in United States is 300.2 per 100,000 annually. Similarly, in Canada the number is somewhere around 236.6 cases.
North America Tumor ablation market is driven by key factors such as growing geriatric population, increasing number of people affected with cancer, technological advancements in the field of ablation. Increasing demand for minimally invasive cancer treatment procedures and favourable reimbursement structures coupled with rising disposable income are some of the other major factors fuelling the growth of the market. However, challenges related to ablation procedures and stringent regulatory guidelines delaying product launches are restraining the market growth.
North America Tumor ablation market is segmented by technology, treatment and application. Based on technology the market is sub-segmented as Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices is the dominating segment accounting for a share of about 35% attributed to its crucial role in solid tumour removal in the body. On the basis of treatment, the market is segmented as Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Surgical Procedures segment accounted for a highest share of around 37% owing to increasing prevalence of liver and breast cancers. By application North America tumor ablation market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer.
1. By Technology Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices
2. By Treatment Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation
3. By Application Liver Cancer Breast Cancer Lung Cancer Prostrate Metastasis and other cancer
Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Galil Medical Inc., Angiodynamics, Mermaid Medical, HealthTronics, EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.
The Tumor Ablation Market study offers the following deliverables:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
